[Chances in surgical treatment of bronchial carcinoma under palliative conditions]
- PMID: 11301888
- DOI: 10.1055/s-2001-12506
[Chances in surgical treatment of bronchial carcinoma under palliative conditions]
Abstract
Palliative surgery aims at symptomatic relief in patients in whom curative therapy seems not feasible. When diagnostic imaging techniques describe advanced stage IIIa, IIIb or IV malignancy, despite of palliative intention curative resection may still be possible. Objective of the present study was to investigate lung cancer patients undergoing surgery with palliative intent and to compare their prognosis with patients whose tumor resection had been complete (R0) or incomplete (R1/R2).
Patients and method: Patients were assigned to one of the three groups on the basis of the following criteria: palliative intention with subsequent complete resection (group I, n = 11); curative intention with subsequent incomplete resection (group II, n = 38), palliative intention with incomplete resection (group III, n = 23). Additionally 3 patients were operated on by explorative thoracotomy. A total number of 75 patients was therefore investigated. Median follow-up period was 34.5 months. Survival rates were calculated using the Kaplan-Meier method.
Results: The following procedures involving resection of pulmonary tissue were performed: pneumonectomy (n = 10), extended pneumonectomy (n = 32), lobectomy (n = 5), extended lobectomy (n = 11), sleeve lobectomy (n = 7), bilobectomy (n = 3), extended bilobectomy (n = 4). The 30 days hospital mortality rate was 13%. Median survival times were 25.5 months in group I, 12.8 months in group II and 7.7 months in group III (statistical significance: group I vs. group II/III, p < 0.05).
Conclusions: Results of the present study show that patients with bronchial carcinoma in advanced tumor stages III and IV may still benefit from pulmonary resection, particularly when reduction of their somatic complaints is considered. In 11 patients, R0 resection was feasible leading to a statistically significant prolongation of their survival rates.
Similar articles
-
Sleeve lobectomy for carcinoma of the lung.J Thorac Cardiovasc Surg. 1979 Dec;78(6):839-49. J Thorac Cardiovasc Surg. 1979. PMID: 228125
-
Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer.Eur J Cardiothorac Surg. 2007 Jan;31(1):95-102. doi: 10.1016/j.ejcts.2006.10.031. Epub 2006 Nov 28. Eur J Cardiothorac Surg. 2007. PMID: 17126556
-
Surgical treatment of primary lung cancer with synchronous brain metastases.J Thorac Cardiovasc Surg. 2001 Sep;122(3):548-53. doi: 10.1067/mtc.2001.116201. J Thorac Cardiovasc Surg. 2001. PMID: 11547308
-
Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. doi: 10.1016/j.athoracsur.2004.04.085. Ann Thorac Surg. 2004. PMID: 15464470 Review.
-
Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancer.Ann Thorac Surg. 2005 Jan;79(1):234-40. doi: 10.1016/j.athoracsur.2004.06.100. Ann Thorac Surg. 2005. PMID: 15620949 Review.
Cited by
-
Morbidity, mortality and long-term outcome of lung cancer resections performed in palliative intent.J Thorac Dis. 2019 Oct;11(10):4308-4318. doi: 10.21037/jtd.2019.09.61. J Thorac Dis. 2019. PMID: 31737316 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical